KalshiVérifier la disponibilitéKYC requis2% de fraisDonnées de résolution vérifiéesGrossièrement calibréProbabilité implicite actuelleBefore October 2027 90%En tête parmi 5 options
Qualite du marche
48 / 100
Faible qualitéVolume 24h
0 €
Liquidité
6,5 k €
Liquidité moyenneAchat / Vente
32.0% / 36.0%
Spread
4.0 pt
Spread modéréDonnées du marché
Mis à jour il y a 13 minutes
16 mai 26, 2:301 janv. 27, 4:59
Tendances
Fonds fictifs uniquement, aucun argent réelCeci n'est pas un conseil financier
Résultat choisi
Before Jan 1, 202736%
Tendance du volume
$132 juil.20j de données27 juil.
Marchés Associés
Hantavirus pandemic in 2026?
98,4 k €Oui: 3%
POLYMARKET
POLYMARKET
# of views of MrBeast video day 3?
6,9 k €26-27M: 78%POLYMARKET
POLYMARKET
New pandemic in 2026?
5,2 k €Oui: 9%POLYMARKET
POLYMARKET
Measles cases in 2026?
2,4 k €Above 3000: 94%KALSHI
KALSHI
Pandemic in 2026?
2 k €Oui: 5%KALSHI
KALSHI
Cyclosporiasis cases reported in the US in 2026?
1,2 k €Above 20k: 34%KALSHI
KALSHIActifs dans ces sujets
Règles
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Oct 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.